rivaroxaban vi.rel pharma
vi.rel pharma s.r.l - rivaroxaban - rivaroxaban
rivaroxaban polpharma
zaklady farmaceutyczne polpharma sa - rivaroxaban - rivaroxaban
rivaroxaban hcs
hcs bv - rivaroxaban - rivaroxaban
rivaroxaban doc
doc generici srl - rivaroxaban - rivaroxaban
diprosalic
organon italia s.r.l. - betametasone - betametasone
xarelto
bayer ag - rivaroxaban - arthroplasty, replacement; venous thromboembolism - agenti antitrombotici - xarelto, co-somministrato con acido acetilsalicilico (asa) da solo o con asa più clopidogrel o ticlopidina, è indicato per la prevenzione di eventi atherothrombotic in pazienti adulti dopo una sindrome coronarica acuta (acs) con elevata biomarcatori cardiaci. xarelto, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. prevenzione del tromboembolismo venoso (tev) in pazienti adulti sottoposti a chirurgia sostitutiva elettiva dell'anca o del ginocchio. trattamento della trombosi venosa profonda (tvp) ed embolia polmonare (ep) e prevenzione della recidiva di tvp e ep nell'adulto. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
retrovir azt 250 mg capsule
viiv healthcare gmbh - zidovudinum - capsule - zidovudinum 250 mg, amyla, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, kapselhülle: gelatina, e 132, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, aqua purificata, kalii hydroxidum, pro capsula corresp. natrium 0.588 - 0.882 mg. - le infezioni da hiv - synthetika
diflucan 50 mg capsule
pfizer ag - fluconazolum - capsule - fluconazolum 50 mg, colore.: e 131, excipiens per la capsula. - antifungini - synthetika
diflucan 150 mg capsule
pfizer ag - fluconazolum - capsule - fluconazolum 150 mg, colore.: e 131, excipiens per la capsula. - antifungini - synthetika